References
Pearlstein TB. Curr Opin Psych 6: 809–815, 1993
Mortola JF. Drug Saf 10: 160–169, 1994
O’Brien PMS. BMJ 307: 1471–1475, 1993
Deeny M, et al. Postgard Med J 67: 450–454, 1991
Jacobsen FM. J Clin Psychiatry 54: 229–234, 1993
Plouffe L Jr, et al. Female Patient 19: 53–60, 1994
Rivera-Tovar A, Frank E. Am J Psychiatry 147: 1634–1636, 1990
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (3rd ed., revised), pp 367–367, Washington, DC, American Psychiatric Association, 1987
Elks ML. South Med J 86: 503–507, 1993
Brandenburg S, et al. Int Clin Psychopharmacol 8: 315–317, 1993
Menkes DB, et al. Int Clin Psychopharmacol 8: 95–102, 1993
Sundblad C, et al. Neuropsychopharmacology 9: 133–145, 1993
Veeninga AT, et al. Psychopharmacology 102: 414–416, 1990
Schmidt PJ, et al. Arch Gen Psychiatry 50: 467–473, 1993
Abraham GE, Hargrove JT. Infertility 3: 155–165, 1980
Skleijen J, et al. Br J Obstet Gynaecol 97: 847–851, 1990
Rights and permissions
About this article
Cite this article
Many options for women with premenstrual syndrome. Drugs Ther. Perspect 3, 10–12 (1994). https://doi.org/10.2165/00042310-199403110-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199403110-00005